TONIX PHARMACEUTICALS HOLDING CORP. Increase (Decrease) in Other Accrued Liabilities
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) reported Increase (Decrease) in Other Accrued Liabilities of -$312.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccruedLiabilities · last filed 2026-08-10
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in other accrued liabilities for the quarter ending 2026-06-30 was $1.75M, a 47.93% decline year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in other accrued liabilities for the quarter ending 2026-03-31 was -$2.06M.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in other accrued liabilities for the quarter ending 2025-12-31 was $10.08M, a 551.29% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in other accrued liabilities for the quarter ending 2025-09-30 was $1.25M, a 163.16% increase year-over-year.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in other accrued liabilities for fiscal 2025 was $11.74M, a 886.97% increase from fiscal 2024.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in other accrued liabilities for fiscal 2024 was $1.19M, a 33.37% decline from fiscal 2023.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in other accrued liabilities for fiscal 2023 was $1.79M, a 48.22% increase from fiscal 2022.
- TONIX PHARMACEUTICALS HOLDING CORP. increase (decrease) in other accrued liabilities for fiscal 2022 was $1.21M, a 31.06% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Accrued Liabilities 3 month | Increase (Decrease) in Other Accrued Liabilities 3 month as first filed | Increase (Decrease) in Other Accrued Liabilities 6 month | Increase (Decrease) in Other Accrued Liabilities 6 month as first filed | Increase (Decrease) in Other Accrued Liabilities 9 month | Increase (Decrease) in Other Accrued Liabilities 9 month as first filed | Increase (Decrease) in Other Accrued Liabilities 12 month | Increase (Decrease) in Other Accrued Liabilities 12 month as first filed | Increase (Decrease) in Other Accrued Liabilities 55 month | Increase (Decrease) in Other Accrued Liabilities 58 month | Increase (Decrease) in Other Accrued Liabilities 61 month | Increase (Decrease) in Other Accrued Liabilities 64 month | Increase (Decrease) in Other Accrued Liabilities 67 month | Increase (Decrease) in Other Accrued Liabilities 70 month | Increase (Decrease) in Other Accrued Liabilities 73 month | Increase (Decrease) in Other Accrued Liabilities 76 month | Increase (Decrease) in Other Accrued Liabilities 79 month | Increase (Decrease) in Other Accrued Liabilities 82 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$312.00K 10-Q · filed 2026-08-10 | $9.77M derived: sum of 3 quarters · filed 2026-08-10 | $11.02M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||||
| 2026-03-31 | -$2.06M 10-Q · filed 2026-05-11 | $8.02M derived: sum of 2 quarters · filed 2026-05-11 | $9.27M derived: sum of 3 quarters · filed 2026-05-11 | $12.63M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||||
| 2025-12-31 | $10.08M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $11.33M derived: sum of 2 quarters · filed 2026-03-12 | $14.70M derived: sum of 3 quarters · filed 2026-08-10 | $11.74M 10-K · filed 2026-03-12 | ||||||||||||||
| 2025-09-30 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $4.61M derived: sum of 2 quarters · filed 2026-08-10 | $1.66M 10-Q · filed 2025-11-10 | $3.21M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||||
| 2025-06-30 | $3.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $413.00K 10-Q · filed 2026-08-10 | $1.96M derived: sum of 3 quarters · filed 2026-08-10 | $2.44M derived: sum of 4 quarters · filed 2026-08-10 | ||||||||||||||
| 2025-03-31 | -$2.95M 10-Q · filed 2026-05-11 | -$1.40M derived: sum of 2 quarters · filed 2026-05-11 | -$927.00K derived: sum of 3 quarters · filed 2026-05-11 | -$14.00K derived: sum of 4 quarters · filed 2026-05-11 | ||||||||||||||
| 2024-12-31 | $1.55M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $2.02M derived: sum of 2 quarters · filed 2026-03-12 | $2.94M derived: sum of 3 quarters · filed 2026-03-12 | $1.19M 10-K · filed 2026-03-12 | ||||||||||||||
| 2024-09-30 | $475.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.39M derived: sum of 2 quarters · filed 2025-11-10 | -$358.00K 10-Q · filed 2025-11-10 | $4.07M derived: sum of 4 quarters · filed 2025-11-10 | ||||||||||||||
| 2024-06-30 | $913.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | -$833.00K 10-Q · filed 2025-08-11 | $3.59M derived: sum of 3 quarters · filed 2025-08-11 | $2.55M derived: sum of 4 quarters · filed 2025-08-11 | ||||||||||||||
| 2024-03-31 | -$1.75M 10-Q · filed 2025-05-12 | $2.68M derived: sum of 2 quarters · filed 2025-05-12 | $1.63M derived: sum of 3 quarters · filed 2025-05-12 | $3.00M derived: sum of 4 quarters · filed 2025-05-12 | ||||||||||||||
| 2023-12-31 | $4.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $3.38M derived: sum of 2 quarters · filed 2025-03-18 | $4.74M derived: sum of 3 quarters · filed 2025-03-18 | $1.79M 10-K · filed 2025-03-18 | ||||||||||||||
| 2023-09-30 | -$1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $317.00K derived: sum of 2 quarters · filed 2024-11-12 | -$2.64M 10-Q · filed 2024-11-12 | -$433.00K derived: sum of 4 quarters · filed 2024-11-12 | ||||||||||||||
| 2023-06-30 | $1.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-16 | -$1.59M 10-Q · filed 2024-08-16 | $614.00K derived: sum of 3 quarters · filed 2024-08-16 | $1.93M derived: sum of 4 quarters · filed 2024-08-16 | ||||||||||||||
| 2023-03-31 | -$2.96M 10-Q · filed 2024-05-13 | -$750.00K derived: sum of 2 quarters · filed 2024-05-13 | $563.00K derived: sum of 3 quarters · filed 2024-05-13 | $280.00K derived: sum of 4 quarters · filed 2024-05-13 | ||||||||||||||
| 2022-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $3.52M derived: sum of 2 quarters · filed 2024-04-01 | $3.24M derived: sum of 3 quarters · filed 2024-04-01 | $1.21M 10-K · filed 2024-04-01 | ||||||||||||||
| 2022-09-30 | $1.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.03M derived: sum of 2 quarters · filed 2023-11-09 | -$1.00M 10-Q · filed 2023-11-09 | $1.89M derived: sum of 4 quarters · filed 2023-11-09 | ||||||||||||||
| 2022-06-30 | -$283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$2.31M 10-Q · filed 2023-08-10 | $580.00K derived: sum of 3 quarters · filed 2023-08-10 | -$152.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||||||||||||
| 2022-03-31 | -$2.03M 10-Q · filed 2023-05-08 | $863.00K derived: sum of 2 quarters · filed 2023-05-08 | $131.00K derived: sum of 3 quarters · filed 2023-05-08 | $1.56M derived: sum of 4 quarters · filed 2023-05-08 | ||||||||||||||
| 2021-12-31 | $2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $2.16M derived: sum of 2 quarters · filed 2023-03-13 | $3.59M derived: sum of 3 quarters · filed 2023-03-13 | $1.75M 10-K · filed 2023-03-13 | ||||||||||||||
| 2021-09-30 | -$732.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $696.00K derived: sum of 2 quarters · filed 2022-11-07 | -$1.15M 10-Q · filed 2022-11-07 | $1.41M derived: sum of 4 quarters · filed 2022-11-07 | ||||||||||||||
| 2021-06-30 | $1.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$415.00K 10-Q · filed 2022-08-08 | $2.14M derived: sum of 3 quarters · filed 2022-08-08 | $3.07M derived: sum of 4 quarters · filed 2022-08-08 | ||||||||||||||
| 2021-03-31 | -$1.84M 10-Q · filed 2022-05-09 | $711.00K derived: sum of 2 quarters · filed 2022-05-09 | $1.64M derived: sum of 3 quarters · filed 2022-05-09 | $1.79M derived: sum of 4 quarters · filed 2022-05-09 | ||||||||||||||
| 2020-12-31 | $2.55M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14 | $3.48M derived: sum of 2 quarters · filed 2022-03-14 | $3.63M derived: sum of 3 quarters · filed 2022-03-14 | $2.91M 10-K · filed 2022-03-14 | ||||||||||||||
| 2020-09-30 | $930.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $1.08M derived: sum of 2 quarters · filed 2021-11-08 | $360.00K 10-Q · filed 2021-11-08 | $1.24M derived: sum of 4 quarters · filed 2021-11-08 | ||||||||||||||
| 2020-06-30 | $146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$570.00K 10-Q · filed 2021-08-09 | $309.00K derived: sum of 3 quarters · filed 2021-08-09 | $583.00K derived: sum of 4 quarters · filed 2021-08-09 | ||||||||||||||
| 2020-03-31 | -$716.00K 10-Q · filed 2021-05-10 | $163.00K derived: sum of 2 quarters · filed 2021-05-10 | $437.00K derived: sum of 3 quarters · filed 2021-05-10 | $499.00K derived: sum of 4 quarters · filed 2021-05-10 | ||||||||||||||
| 2019-12-31 | $879.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $1.15M derived: sum of 2 quarters · filed 2021-03-15 | $1.22M derived: sum of 3 quarters · filed 2021-03-15 | $462.00K 10-K · filed 2021-03-15 | ||||||||||||||
| 2019-09-30 | $274.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $336.00K derived: sum of 2 quarters · filed 2020-11-09 | -$417.00K 10-Q · filed 2020-11-09 | -$386.00K 10-Q · filed 2019-11-08 | -$457.00K derived: sum of 4 quarters · filed 2020-11-09 | |||||||||||||
| 2019-06-30 | $62.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | -$691.00K 10-Q · filed 2020-08-10 | -$731.00K derived: sum of 3 quarters · filed 2020-08-10 | -$311.00K derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||||
| 2019-03-31 | -$753.00K 10-Q · filed 2020-05-12 | -$750.00K 10-Q · filed 2019-05-13 | -$793.00K derived: sum of 2 quarters · filed 2020-05-12 | -$373.00K derived: sum of 3 quarters · filed 2020-05-12 | -$606.00K derived: sum of 4 quarters · filed 2020-05-12 | |||||||||||||
| 2018-12-31 | -$40.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-24 | $380.00K derived: sum of 2 quarters · filed 2020-03-24 | $147.00K derived: sum of 3 quarters · filed 2020-03-24 | $410.00K 10-K · filed 2020-03-24 | ||||||||||||||
| 2018-09-30 | $420.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $187.00K derived: sum of 2 quarters · filed 2019-11-08 | $450.00K 10-Q · filed 2019-11-08 | $799.00K derived: sum of 4 quarters · filed 2019-11-08 | ||||||||||||||
| 2018-06-30 | -$233.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $30.00K 10-Q · filed 2019-08-12 | $379.00K derived: sum of 3 quarters · filed 2019-08-12 | $259.00K derived: sum of 4 quarters · filed 2019-08-12 | ||||||||||||||
| 2018-03-31 | $263.00K 10-Q · filed 2019-05-13 | $612.00K derived: sum of 2 quarters · filed 2019-05-13 | $492.00K derived: sum of 3 quarters · filed 2019-05-13 | $202.00K derived: sum of 4 quarters · filed 2019-05-13 | ||||||||||||||
| 2017-12-31 | $349.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $229.00K derived: sum of 2 quarters · filed 2019-03-18 | -$61.00K derived: sum of 3 quarters · filed 2019-03-18 | -$361.00K 10-K · filed 2019-03-18 | ||||||||||||||
| 2017-09-30 | -$120.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$410.00K derived: sum of 2 quarters · filed 2018-11-09 | -$710.00K 10-Q · filed 2018-11-09 | -$1.18M derived: sum of 4 quarters · filed 2018-11-09 | ||||||||||||||
| 2017-06-30 | -$290.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | -$590.00K 10-Q · filed 2018-08-13 | -$1.06M derived: sum of 3 quarters · filed 2018-08-13 | -$1.60M derived: sum of 4 quarters · filed 2018-08-13 | ||||||||||||||
| 2017-03-31 | -$300.00K 10-Q · filed 2018-05-11 | -$307.00K 10-Q · filed 2017-05-12 | -$766.00K derived: sum of 2 quarters · filed 2018-05-11 | -$1.31M derived: sum of 3 quarters · filed 2018-05-11 | -$916.00K derived: sum of 4 quarters · filed 2018-05-11 | |||||||||||||
| 2016-12-31 | -$466.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$1.01M derived: sum of 2 quarters · filed 2018-03-09 | -$616.00K derived: sum of 3 quarters · filed 2018-03-09 | -$2.26M 10-K · filed 2018-03-09 | -$2.19M 10-K · filed 2017-04-13 | |||||||||||||
| 2016-09-30 | -$548.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$150.00K derived: sum of 2 quarters · filed 2017-11-06 | -$1.79M 10-Q · filed 2017-11-06 | -$1.73M 10-Q · filed 2016-11-10 | -$869.00K derived: sum of 4 quarters · filed 2017-11-06 | |||||||||||||
| 2016-06-30 | $398.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$1.25M 10-Q · filed 2017-08-11 | -$1.22M 10-Q · filed 2016-08-05 | -$321.00K derived: sum of 3 quarters · filed 2017-08-11 | $598.00K derived: sum of 4 quarters · filed 2017-08-11 | |||||||||||||
| 2016-03-31 | -$1.65M 10-Q · filed 2017-05-12 | -$719.00K derived: sum of 2 quarters · filed 2017-05-12 | $200.00K derived: sum of 3 quarters · filed 2017-05-12 | $518.00K derived: sum of 4 quarters · filed 2017-05-12 | ||||||||||||||
| 2015-12-31 | $926.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-04-13 | $1.84M derived: sum of 2 quarters · filed 2017-04-13 | $2.16M derived: sum of 3 quarters · filed 2017-04-13 | $1.87M 10-K · filed 2017-04-13 | ||||||||||||||
| 2015-09-30 | $919.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $1.24M derived: sum of 2 quarters · filed 2016-11-10 | $948.00K 10-Q · filed 2016-11-10 | $1.80M derived: sum of 4 quarters · filed 2016-11-10 | ||||||||||||||
| 2015-06-30 | $318.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $29.00K 10-Q · filed 2016-08-05 | $885.00K derived: sum of 3 quarters · filed 2016-08-05 | $1.33M derived: sum of 4 quarters · filed 2016-08-05 | ||||||||||||||
| 2015-03-31 | -$289.00K 10-Q · filed 2016-05-06 | $567.00K derived: sum of 2 quarters · filed 2016-05-06 | $1.02M derived: sum of 3 quarters · filed 2016-05-06 | $1.01M derived: sum of 4 quarters · filed 2016-05-06 | ||||||||||||||
| 2014-12-31 | $856.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $1.31M derived: sum of 2 quarters · filed 2016-03-03 | $1.30M derived: sum of 3 quarters · filed 2016-03-03 | $729.00K 10-K · filed 2016-03-03 | ||||||||||||||
| 2014-09-30 | $450.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $445.00K derived: sum of 2 quarters · filed 2015-11-06 | -$127.00K 10-Q · filed 2015-11-06 | $187.00K derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||||||
| 2014-06-30 | -$5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$577.00K 10-Q · filed 2015-08-07 | -$263.00K derived: sum of 3 quarters · filed 2016-03-03 | -$11.00K derived: sum of 4 quarters · filed 2016-03-03 | ||||||||||||||
| 2014-03-31 | -$572.00K 10-Q · filed 2015-05-08 | -$258.00K derived: sum of 2 quarters · filed 2016-03-03 | -$6.00K derived: sum of 3 quarters · filed 2016-03-03 | $248.00K derived: sum of 4 quarters · filed 2016-03-03 | $688.00K 10-Q · filed 2014-05-13 | |||||||||||||
| 2013-12-31 | $314.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-03 | $566.00K derived: sum of 2 quarters · filed 2016-03-03 | $820.00K derived: sum of 3 quarters · filed 2016-03-03 | $856.00K 10-K · filed 2016-03-03 | $1.26M 10-K · filed 2014-03-28 | |||||||||||||
| 2013-09-30 | $252.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $506.00K derived: sum of 2 quarters · filed 2014-11-07 | $542.00K 10-Q · filed 2014-11-07 | $542.26K 10-Q · filed 2013-11-13 | $708.93K derived: sum of 4 quarters · filed 2014-11-07 | $946.32K 10-Q · filed 2013-11-13 | ||||||||||||
| 2013-06-30 | $254.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $290.00K 10-Q · filed 2014-08-08 | $289.99K 10-Q · filed 2013-08-14 | $456.93K derived: sum of 3 quarters · filed 2014-08-08 | $300.49K derived: sum of 4 quarters · filed 2014-08-08 | $694.05K 10-Q · filed 2013-08-14 | ||||||||||||
| 2013-03-31 | $36.00K 10-Q · filed 2014-05-13 | $35.99K 10-Q · filed 2013-05-07 | $202.93K derived: sum of 2 quarters · filed 2014-05-13 | $46.48K derived: sum of 3 quarters · filed 2014-05-13 | $240.50K derived: sum of 4 quarters · filed 2014-05-13 | $440.06K 10-Q · filed 2013-05-07 | ||||||||||||
| 2012-12-31 | $166.93K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $10.48K derived: sum of 2 quarters · filed 2014-03-28 | $204.50K derived: sum of 3 quarters · filed 2014-03-28 | $293.00K 10-K · filed 2014-03-28 | $293.13K 10-K · filed 2013-03-11 | $404.06K 10-K/A · filed 2013-11-22 | ||||||||||||
| 2012-09-30 | -$156.44K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $37.57K derived: sum of 2 quarters · filed 2013-11-13 | $126.07K 10-Q · filed 2013-11-13 | $117.24K derived: sum of 4 quarters · filed 2013-11-22 | $237.01K 10-Q · filed 2012-11-14 | |||||||||||||
| 2012-06-30 | $194.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $282.51K 10-Q · filed 2013-08-14 | $273.68K derived: sum of 3 quarters · filed 2013-11-22 | $290.20K derived: sum of 4 quarters · filed 2013-11-22 | $393.45K 10-Q · filed 2012-08-13 | |||||||||||||
| 2012-03-31 | $88.50K 10-Q · filed 2013-05-07 | $79.67K derived: sum of 2 quarters · filed 2013-11-22 | $96.18K derived: sum of 3 quarters · filed 2013-11-22 | $83.60K derived: sum of 4 quarters · filed 2013-11-22 | $199.44K 10-Q · filed 2012-05-15 | |||||||||||||
| 2011-12-31 | -$8.83K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-11-22 | $7.68K derived: sum of 2 quarters · filed 2013-11-22 | -$4.90K derived: sum of 3 quarters · filed 2013-11-22 | -$12.30K 10-K/A · filed 2013-11-22 | $110.94K 10-K · filed 2012-03-30 | |||||||||||||
| 2011-09-30 | $16.51K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $3.93K derived: sum of 2 quarters · filed 2012-11-14 | -$3.47K 10-Q · filed 2012-11-14 | |||||||||||||||
| 2011-06-30 | -$12.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-13 | -$19.98K 10-Q · filed 2012-08-13 | ||||||||||||||||
| 2011-03-31 | -$7.40K 10-Q · filed 2012-05-15 | |||||||||||||||||
| 2010-12-31 | -$34.79K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |